OPORF
Price:
$0.1096
Market Cap:
$54.38M
hVIVO plc functions as a contract research organization and pharmaceutical service provider, primarily dedicated to evaluating vaccines and antiviral medications. This is achieved through specialized human challenge clinical trials. The company extends its services to a varied clientele, encompassing major pharmaceutical and biotechnology firms, governmental bodies, and public health agencies. A significant aspect of its operations is a comprehensive array of human challenge study models. These cover conditions such as respiratory syncytial virus (RSV), influenza, human rhinovirus, asthma, malaria, chronic cough, and chronic obstructive pulmonary disease (COPD), with a COVID-19 model current...[Read more]
Industry
Biotechnology
IPO Date
2020-06-05
Stock Exchange
OTC
Ticker
OPORF
According to hVIVO plc’s latest financial reports and current stock price. The company's current ROE is -14.65%. This represents a change of -681.86% compared to the average of 2.52% of the last 4 quarters.
The mean historical ROE of hVIVO plc over the last ten years is -31.48%. The current -14.65% ROE has changed -53.45% with respect to the historical average. Over the past ten years (40 quarters), OPORF's ROE was at its highest in in the December 2011 quarter at 484.40%. The ROE was at its lowest in in the December 2019 quarter at -139.92%.
Average
-31.48%
Median
-9.77%
Minimum
-195.31%
Maximum
46.95%
Discovering the peaks and valleys of hVIVO plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.27%
Maximum Annual ROE = 46.95%
Minimum Annual Increase = -1323.16%
Minimum Annual ROE = -195.31%
| Year | ROE | Change |
|---|---|---|
| 2025 | -15.71% | -165.87% |
| 2024 | 23.84% | -49.21% |
| 2023 | 46.95% | -1323.16% |
| 2022 | -3.84% | 972.61% |
| 2021 | -0.36% | -99.26% |
| 2020 | -48.40% | -75.22% |
| 2019 | -195.31% | 78.30% |
| 2018 | -109.54% | 523.57% |
| 2017 | -17.57% | -444.47% |
| 2016 | 5.10% | 3.27% |
The current ROE of hVIVO plc (OPORF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
18.36%
5-year avg
10.18%
10-year avg
-31.48%
hVIVO plc’s ROE is greater than Silence Therapeutics plc (-121.71%), greater than Oryzon Genomics S.A. (-2.03%), greater than Transgene S.A. (-63.53%), less than Santhera Pharmaceuticals Holding AG (684.83%), less than Frontage Holdings Corporation (1.98%), less than Hansa Biopharma AB (publ) (201.60%), greater than Genfit S.A. (-596.44%), greater than Orpea S.A. (-17.66%), less than China Evergrande New Energy Vehicle Group Limited (20.82%), less than Benchmark Holdings plc (29.28%),
| Company | ROE | Market cap |
|---|---|---|
| -121.71% | $313.17M | |
| -2.03% | $282.54M | |
| -63.53% | $122.57M | |
| 684.83% | $344.83M | |
| 1.98% | $223.05M | |
| 201.60% | $245.80M | |
| -596.44% | $499.80M | |
| -17.66% | $2.29B | |
| 20.82% | $2.17M | |
| 29.28% | $225.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like hVIVO plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like hVIVO plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is hVIVO plc's ROE?
How is the ROE calculated for hVIVO plc (OPORF)?
What is the highest ROE for hVIVO plc (OPORF)?
What is the 3-year average ROE for hVIVO plc (OPORF)?
What is the 5-year average ROE for hVIVO plc (OPORF)?
How does the current ROE for hVIVO plc (OPORF) compare to its historical average?